Financial Performance - The company has not yet achieved profitability since its listing[3]. - Sansure Biotech reported a significant increase in revenue, achieving a year-over-year growth of 25% in Q3 2023[15]. - The company achieved operating revenue of CNY 1,458,061,552.96 in 2024, representing a year-on-year growth of 44.78%[22]. - The net profit attributable to shareholders of the listed company was CNY 275,596,143.87, a decrease of 24.23% compared to the previous year[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 182.25% to CNY 202,227,363.25[22]. - The net cash flow from operating activities reached CNY 274,447,856.11, marking a significant increase of 530.34%[22]. - Basic earnings per share decreased by 24.19% to CNY 0.47, while diluted earnings per share remained the same[23]. - The company achieved a revenue of 308.6 million RMB in the immunodiagnostic market in 2023, reflecting a year-on-year growth of 10.4%[88]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion yuan, representing a 25% year-over-year growth[167]. Dividend Policy - The company plans to distribute a cash dividend of 2.75 RMB per 10 shares (including tax), totaling approximately 157.9 million RMB based on the current total share capital of 579,388,006 shares, after deducting 5,209,401 shares in the repurchase account[5]. - The company plans to implement annual cash dividends of no less than 300 million yuan over the next three years, having already distributed a total of over 2.2 billion yuan in dividends since its listing[48]. - For the 2023 fiscal year, the company distributed a cash dividend of RMB 2.00 per 10 shares, and for the 2024 fiscal year, it plans to distribute RMB 2.75 per 10 shares[191]. - The cash dividend amount (including tax) distributed was CNY 301,329,669.63, which represents 109.34% of the net profit attributable to ordinary shareholders[195]. Research and Development - The company is investing heavily in R&D, with a budget allocation of 15% of total revenue towards the development of next-generation sequencing technologies[16]. - The company's R&D investment accounted for 24.79% of operating revenue, reflecting a strategic focus on innovation[23]. - R&D investment for 2024 totaled CNY 361.38 million, up 53.36% year-on-year, accounting for 24.79% of operating revenue[34]. - The company has filed 359 new patents during the reporting period, including 154 invention patents, and has a total of 1,253 patents[78]. - The company is focusing on new technologies such as multi-PCR, NGS, and CRISPR, aiming for simplification, automation, and systematization in molecular diagnostics[65]. - The company has developed multiple detection technologies, including tNGS, mNGS, and WGS, significantly improving clinical diagnosis efficiency and accuracy in areas such as tuberculosis and respiratory infections[73]. Market Expansion and Strategy - Sansure Biotech plans to enter new international markets, targeting a 20% increase in overseas sales by the end of 2024[16]. - The company is actively pursuing internationalization and innovation-driven strategies, particularly in key areas such as respiratory, maternal and child health, blood source, and sequencing technologies[22]. - The company is exploring potential acquisitions to strengthen its market position, with a focus on companies in the biotech sector[167]. - The company has established overseas subsidiaries in countries such as Indonesia, France, the UK, and the US, expanding its global footprint to over 160 countries[97]. - The company is focusing on enhancing its core technologies in molecular diagnostics, including high-precision "magnetic bead method" and "POCT mobile molecular diagnostics"[91]. Corporate Governance and Compliance - The company has received a standard unqualified audit report from Zhongchao Zhonghuan Accounting Firm[4]. - The company has not disclosed any special arrangements for corporate governance[8]. - The company adheres to a strict governance framework in compliance with relevant laws and regulations[156]. - The audit committee confirmed the accuracy and completeness of the annual and quarterly reports, ensuring no false statements or omissions[178]. Risk Management - The company has detailed various risks and countermeasures in its annual report, which investors should review[3]. - The company faces risks related to market competition, quality control, and potential changes in government policies affecting tax incentives and subsidies[103][104]. Talent and Workforce - The company has introduced nearly 20 PhD graduates from renowned domestic and international universities in 2024 to enhance its talent pool[43]. - The number of R&D personnel increased to 581, accounting for 24.77% of the total workforce, with an average salary of 20.29 million RMB[90]. - The company has established a training program to enhance employee skills and promote leadership development through its "Saint Xiang Higher School"[187]. Social Responsibility - The company has donated over 400 million yuan in cash and materials for public health events and disaster relief efforts[47]. - The company has been recognized with the "National Public Health Contribution Award" for its cervical cancer HPV screening project in Sierra Leone[41]. Stock Incentives - The company has implemented stock incentives for various personnel, with values ranging from 8.05 to 230.92[162]. - The total number of stock incentives granted during the reporting period was 257,655 units, with a total value of 308,387[162]. - The company continues to expand its stock incentive programs to attract and retain talent in key positions[162].

Dividend and Share Repurchase - The company plans to distribute a cash dividend of RMB 0.9341 per 10 shares, totaling RMB 337,135,626.45 (including tax) based on a total share count of 3,609,202,724 shares after excluding repurchased shares[6]. - The total amount for cash dividends and share repurchase in 2024 is RMB 903,338,047.92, which accounts for 40.20% of the net profit attributable to shareholders of the listed company[6]. - As of April 24, 2025, the company holds 79,014,600 shares in the repurchase account, which will not participate in the profit distribution[7]. Financial Performance - The company's operating revenue for 2024 was CNY 46.17 billion, a decrease of 10.03% compared to CNY 51.31 billion in 2023[24]. - Net profit attributable to shareholders for 2024 was CNY 2.25 billion, down 22.60% from CNY 2.90 billion in 2023[24]. - The net cash flow from operating activities decreased by 70.49% to CNY 2.43 billion in 2024, compared to CNY 8.23 billion in 2023[24]. - Basic earnings per share for 2024 were CNY 0.61, a decline of 28.24% from CNY 0.85 in 2023[25]. - The company's total assets decreased by 0.63% to CNY 65.36 billion at the end of 2024, compared to CNY 65.78 billion at the end of 2023[24]. - The net assets attributable to shareholders increased by 6.93% to CNY 22.90 billion at the end of 2024, up from CNY 21.42 billion at the end of 2023[24]. Revenue Growth and Market Expansion - The company reported a significant increase in revenue, achieving a total of $1.2 billion for the quarter, representing a 25% year-over-year growth[18]. - User data showed an increase in active users, reaching 5 million, which is a 15% increase compared to the previous quarter[18]. - The company provided guidance for the next quarter, expecting revenue to be between $1.3 billion and $1.5 billion, indicating a growth rate of 10% to 25%[18]. - Market expansion plans include entering three new international markets by the end of the fiscal year, aiming for a 30% increase in global sales[18]. Research and Development - The company is investing $200 million in R&D for new technologies, focusing on improving energy storage systems and inverter efficiency[18]. - Research and development expenses accounted for 1.86% of operating revenue in 2024, an increase of 0.49 percentage points from 1.37% in 2023[25]. - Research and development investment reached CNY 856.65 million, a year-on-year increase of 21.67%[48]. - The company has applied for a total of 4,890 patents, maintaining 2,300 effective patents, including 376 invention patents domestically[48]. Product Development and Technology - New product launches included a solar panel with a 22% efficiency rate, which is expected to capture a larger market share[18]. - The company has achieved a maximum component power output of 740W through technological advancements[50]. - The company has developed a high-efficiency energy storage system with a rated capacity of 61.8 KWh and a maximum temperature difference of ≤3℃[136]. - The company has introduced a series of new technologies for photovoltaic inverters, including high-efficiency designs for large current photovoltaic components and intelligent control algorithms[122]. Market Position and Competition - The company has maintained a leading position in global photovoltaic module shipments for 15 consecutive years, consistently ranking in the top tier of suppliers[62]. - The company is recognized as a leading manufacturer of photovoltaic modules and energy storage systems, consistently ranking among the top in global shipments for 15 consecutive years[102]. - The company operates in a highly competitive photovoltaic industry, with increasing competition potentially affecting its operational performance[155]. Risks and Challenges - The company faces risks related to raw material price fluctuations, which could significantly impact profit margins[152]. - The company is exposed to risks from changes in tax incentives and policies that could adversely affect its financial performance[154]. - The company does not rule out the risk of future tariff payments or losses of deposits due to ongoing trade disputes[162]. Sales and Production - In 2024, the company sold 31.1 GW of photovoltaic products and 6.5 GWh of energy storage products, maintaining a leading position globally[165]. - The company's photovoltaic component sales revenue was CNY 31.48 billion, down 25.62% year-on-year, with a gross margin of 12.75%[170]. - The production volume of photovoltaic components was 31,422 MW, with a sales volume of 31,079 MW, reflecting a slight increase in sales[172]. International Operations - The company has established or planned production bases in Thailand, the USA, and Vietnam, with overseas sales revenue accounting for over 70% of total revenue[147]. - As of December 31, 2024, the company has a potential order reserve of 79 GWh for overseas large-scale energy storage projects[148].

Financial Performance - Total assets increased by 7.34% to CNY 5,458,597,353.56 in 2024 from CNY 5,085,195,018.26 in 2023[39] - Operating revenue decreased by 15.42% to CNY 2,233,776,309.22 in 2024 compared to CNY 2,640,930,848.22 in 2023[39] - Net profit attributable to shareholders decreased by 34.69% to CNY 107,065,006.86 in 2024 from CNY 163,934,934.32 in 2023[39] - The net profit after deducting non-recurring gains and losses decreased by 45.98% to CNY 66,044,202.71 in 2024 compared to CNY 122,262,229.85 in 2023[39] - The net cash flow from operating activities decreased by 30.00% to CNY 190,975,186.00 in 2024 from CNY 272,820,666.59 in 2023[39] - The weighted average return on net assets decreased by 1.46 percentage points to 2.70% in 2024 from 4.16% in 2023[39] - Research and development expenditure accounted for 19.89% of operating revenue in 2024, an increase of 2.48 percentage points from 17.41% in 2023[39] - In Q1 2024, the company reported an operating revenue of CNY 443,427,489.50, with a net profit attributable to shareholders of CNY -6,675,129.96[44] - In Q2 2024, the operating revenue increased to CNY 644,764,289.87, with a net profit attributable to shareholders of CNY 93,938,388.22[44] - The company experienced a significant cash inflow in Q4 2024, with a net cash flow from operating activities of CNY 312,171,850.15[44] - The company's revenue for the reporting period was 2.234 billion yuan, a decrease of 15.42% year-on-year[53] - The net profit attributable to shareholders was 107 million yuan, down 34.69% compared to the same period last year[53] - The gross profit margin improved to 34.66%, an increase of 3.72 percentage points year-on-year[53] Dividend Distribution - The company plans to distribute a cash dividend of 0.25 yuan per 10 shares, totaling approximately 11.37 million yuan (including tax) based on the current total share capital of 463.5 million shares[5] - The total cash dividend for the year amounts to approximately 163.90 million yuan, which represents 153.08% of the net profit attributable to shareholders of the parent company[5] Product Development and Innovation - The company has established a comprehensive product matrix in machine vision, including prism cameras, area array cameras, line scan cameras, and smart cameras, to meet diverse imaging needs across various industries[12] - The company has developed an industrial general vision large model, F.Brain, to address detection challenges in industrial manufacturing, particularly for small sample and fragmented scenarios[12] - The company is actively expanding its product offerings in optical communication, focusing on next-generation products such as OCS all-optical switches and automated photonic wire bonding solutions[10] - The company plans to launch a series of innovative products and solutions in the AI and optical communication fields, including smart factory solutions and 3D detection applications[53] - The current AI-driven market is still in its early stages, with expectations for significant scale effects as the market matures[53] - The company is undergoing a strategic shift driven by AI demand, marking 2024 as a pivotal year for this transition[53] Strategic Partnerships and Market Position - The company has formed strategic partnerships with leading clients such as Apple, Foxconn, Huawei, and Xiaomi, leveraging over 20 years of industry experience[11] - The company has a leading position in the machine vision industry, serving major clients such as Apple, Huawei, and CATL, and has received multiple national awards for its technological advancements[27] - The Chinese machine vision industry is transitioning from low-end to high-end markets, with significant growth opportunities as domestic companies close the technology gap with international competitors[23] Technology and Research - The company has established a research and development model that includes general technology research and application product development, focusing on four core technologies: optical imaging, intelligent software, intelligent algorithms, and precision automation[18] - New technologies such as deep learning and embedded vision are expanding the diversity of machine vision products and solutions, significantly increasing market potential[28] - Deep learning enhances traditional machine vision algorithms, achieving up to 99% accuracy in applications within the 3C electronics and new energy sectors, while reducing hardware procurement costs[30] - Embedded vision systems integrate machine vision technology into embedded systems, improving development speed and system reliability[31] Sales and Production Model - The sales model is primarily direct sales, supplemented by a distribution model, allowing the company to maintain effective communication with well-known industry clients and respond quickly to customer needs[19] - The production model is based on a "sales-driven production" approach, combining in-house and outsourced production to optimize resource allocation and cost efficiency[22] - The company has implemented a comprehensive supplier evaluation and supply chain management system, enhancing procurement decision-making efficiency and quality[20] Efficiency and Yield Improvement - The company’s intelligent visual equipment significantly enhances detection efficiency and product yield compared to manual inspection methods[13] - The company’s FZMotion optical motion capture system offers industry-leading high-precision 3D positioning and tracking capabilities, enabling real-time calculations of human skeletal movements[15] - The company’s Lustage light field modeling system creates high-precision digital assets for human models and lighting material characteristics[15] - The company focuses on high-end optical fiber devices and instruments, establishing long-term strategic partnerships with renowned global suppliers[16]

Financial Performance - The company's operating revenue for the third quarter was ¥223,489,358.30, a decrease of 26.21% compared to the same period last year[4]. - The net profit attributable to shareholders of the listed company was -¥22,872,407.57 for the third quarter, with a year-to-date net profit of ¥46,515,406.79, reflecting a 20.92% increase year-on-year[4]. - Total revenue for the first three quarters of 2024 reached ¥792,459,841.33, an increase of 6.9% compared to ¥741,660,847.50 in the same period of 2023[20]. - Net profit for the first three quarters of 2024 was ¥46,515,406.79, compared to ¥38,468,202.85 in 2023, representing a growth of 21%[21]. - The company's operating revenue for the first three quarters of 2024 reached ¥883,223,872.10, representing a 19.9% increase compared to ¥736,654,255.68 in the same period of 2023[31]. - The net profit for the first three quarters of 2024 was ¥101,941,781.52, a significant increase of 191.5% from ¥34,937,894.86 in the first three quarters of 2023[32]. Research and Development - The total R&D investment for the third quarter was ¥79,123,192.56, an increase of 52.47% compared to the same period last year, and accounted for 35.40% of operating revenue[5][10]. - Research and development expenses increased significantly to ¥187,046,682.66, up from ¥135,817,708.53, marking a rise of 37.7%[21]. - Research and development expenses increased to ¥174,008,749.31 in 2024, up from ¥130,156,291.29 in 2023, indicating a focus on innovation and new technology[31]. - The company plans to continue increasing its investment in technology research and development to enhance innovation capabilities[9]. Assets and Liabilities - The total assets at the end of the reporting period were ¥6,916,888,271.37, representing a 5.99% increase from the end of the previous year[5]. - Total assets as of the reporting date amounted to ¥6,916,888,271.37, an increase from ¥6,525,692,550.87, reflecting a growth of 6%[18]. - Total liabilities increased to ¥2,109,063,097.30 from ¥1,787,408,624.22, indicating a rise of 18%[18]. - The total liabilities increased to ¥2,136,190,816.41 in 2024 from ¥1,798,379,518.30 in 2023, reflecting a growth in financial obligations[29]. - The company's equity attributable to shareholders rose to ¥4,807,825,174.07 from ¥4,738,283,926.65, an increase of 1.5%[19]. Cash Flow - The net cash flow from operating activities was -¥233,877,728.29 year-to-date, indicating a significant cash outflow[5]. - Cash inflows from operating activities for the first three quarters of 2024 amount to CNY 738,502,896.24, compared to CNY 488,930,189.47 in the same period of 2023, reflecting a growth of approximately 50.9%[25]. - The net cash flow from operating activities for the first three quarters of 2024 is -CNY 233,877,728.29, an improvement from -CNY 263,173,641.02 in the previous year[25]. - The cash inflow from operating activities was ¥742,191,982.90 in the first three quarters of 2024, compared to ¥475,124,149.28 in the same period of 2023, showing improved cash generation[33]. - The company reported a total cash outflow from operating activities of 998,874,601.50, compared to 778,796,633.46 previously, indicating increased operational expenses[34]. Shareholder Information - Total number of shareholders at the end of the reporting period is 8,575[12]. - The largest shareholder, Zhe Shengyang, holds 45,041,825 shares, representing 16.57% of total shares[12]. - The second-largest shareholder, Pingxiang Jingyi Business Information Consulting Partnership, holds 18,752,471 shares, representing 6.9%[12]. - The top 10 shareholders include individuals and entities with varying ownership percentages, with the largest being Zhe Shengyang at 16.57%[12]. - The company has not disclosed any significant related party transactions among the top shareholders[13]. Financial Management - The weighted average return on net assets decreased by 137.05 basis points to -0.48% for the third quarter[5][9]. - The company reported a decrease in financial expenses to ¥6,411,064.34 from ¥18,640,265.75, a reduction of 65.6%[21]. - The financial expenses decreased significantly to ¥5,941,417.08 in 2024 from ¥18,394,732.34 in 2023, suggesting improved cost management[31]. - The company reported an investment income of ¥16,263,586.37 in 2024, a recovery from a loss of ¥62,009.42 in 2023, highlighting better investment performance[31]. Other Information - The report indicates that there are no other important reminders regarding the company's operational status during the reporting period[16]. - The financial statements are unaudited for the period ending September 30, 2024[16]. - The company will not apply new accounting standards starting in 2024, maintaining current reporting practices[35].

Financial Performance - The company's operating revenue for Q1 2024 reached CNY 211,564,738.30, representing a year-on-year increase of 59.13%[3]. - The net profit attributable to shareholders was CNY 957,500.30, while the net profit excluding non-recurring gains and losses was CNY -14,219,746.81[3][7]. - The total operating revenue for Q1 2024 was CNY 211,564,738.30, representing an increase of 59.0% compared to CNY 132,953,332.50 in Q1 2023[18]. - The net profit for Q1 2024 was CNY 957,500.30, a significant improvement from a net loss of CNY 28,494,672.82 in Q1 2023[19]. - The total comprehensive income for Q1 2024 was ¥5.56 million, compared to a loss of ¥25.26 million in Q1 2023[31]. Research and Development - The total R&D investment amounted to CNY 54,405,526.23, reflecting a growth of 32.01% compared to the same period last year[4][8]. - Research and development expenses increased to CNY 54,405,526.23 in Q1 2024, up from CNY 41,213,359.94 in Q1 2023, indicating a focus on innovation[18]. - R&D expenses increased to ¥51.09 million in Q1 2024, compared to ¥39.74 million in Q1 2023, marking a growth of 28.6%[30]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 6,445,025,565.45, a decrease of 1.24% from the end of the previous year[4]. - The company's total assets amounted to RMB 6,445,025,565.45, a decrease from RMB 6,525,692,550.87 on December 31, 2023[13]. - The company's current assets totaled RMB 4,540,169,016.90, down from RMB 4,763,884,195.06 at the end of 2023, indicating a decline of approximately 4.7%[14]. - The total liabilities decreased to CNY 1,676,199,923.49 in Q1 2024 from CNY 1,787,408,624.22 in Q1 2023, reflecting improved financial health[16]. - The company's total liabilities decreased to 1,696,758,002.34 RMB from 1,798,379,518.30 RMB[27]. Cash Flow - The cash flow from operating activities was CNY -196,703,653.63, indicating a significant outflow[4]. - The cash flow from operating activities for Q1 2024 was CNY 169,244,511.47, compared to CNY 105,032,341.76 in Q1 2023, showing a positive trend in cash generation[21]. - The net cash flow from operating activities was -196,703,653.63 RMB, compared to -216,564,313.83 RMB in the previous period, indicating an improvement[22]. - Cash flow from investing activities resulted in a net outflow of ¥1.76 billion in Q1 2024, compared to a net outflow of ¥46.58 million in Q1 2023[33]. - Cash flow from financing activities showed a net outflow of ¥9.91 million in Q1 2024, a decrease from a net inflow of ¥139.94 million in Q1 2023[33]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,893[10]. - The top shareholder, Zhe Shengyang, held 32,172,732 shares, accounting for 16.57% of the total shares[10]. - The company reported a total of 32,172,732 shares held by the largest shareholder, representing a significant portion of the total shares outstanding[12]. - The top ten shareholders collectively held a substantial number of shares, with the largest shareholder holding 32,172,732 shares, indicating strong insider ownership[12]. Operational Metrics - The basic and diluted earnings per share were both CNY 0.005, showing an increase from the previous year[4][8]. - The weighted average return on net assets was 0.02%[4]. - The company experienced a decrease of 5.28 percentage points in the ratio of R&D investment to operating revenue, which stood at 25.72%[4]. - The company reported a gross profit margin of approximately 40.0% in Q1 2024, compared to 48.0% in Q1 2023[18]. - The financial expenses decreased significantly to CNY 1,600,441.35 in Q1 2024 from CNY 4,712,671.18 in Q1 2023, suggesting better cost management[19].

Financial Performance - The company's revenue for Q1 2025 was ¥181,223,359.02, representing a 25.74% increase compared to ¥144,126,501.08 in the same period last year[3] - The net profit attributable to shareholders was -¥164,149,138.43, worsening from -¥58,449,865.10 year-on-year[3] - The net loss for Q1 2025 was ¥164,206,032.59, compared to a net loss of ¥58,490,954.70 in Q1 2024, indicating a significant decline in profitability[17] - The total comprehensive income attributable to the parent company was -164,149,138.43 CNY for Q1 2025, compared to -58,449,865.10 CNY in Q1 2024, indicating a significant decline[18] - Basic and diluted earnings per share were both -0.41 CNY in Q1 2025, down from -0.15 CNY in Q1 2024[18] Cash Flow and Liquidity - The net cash flow from operating activities improved to -¥65,758,885.94 from -¥244,210,749.06 in the previous year[3] - Cash inflows from operating activities totaled 190,807,174.91 CNY in Q1 2025, a decrease of 21.3% from 242,612,539.09 CNY in Q1 2024[18] - Cash outflows from operating activities were 256,566,060.85 CNY in Q1 2025, down from 486,823,288.15 CNY in Q1 2024, reflecting a reduction of 47.4%[18] - Cash and cash equivalents decreased to RMB 309,326,875.95 from RMB 504,492,493.70, representing a decline of 38.67%[12] - The company reported cash and cash equivalents of CNY 121.94 million at the end of Q1 2025, down from CNY 426.17 million at the end of Q1 2024[29] Research and Development - Research and development expenses totaled ¥60,183,560.66, a 52.48% increase from ¥39,469,634.15 in the same period last year[3] - R&D expenses accounted for 33.21% of revenue, up from 27.39% year-on-year, indicating a strategic focus on innovation[4] - The company plans to continue increasing investment in R&D to enhance product innovation and maintain competitive advantage in the market[7] - Research and development expenses increased to ¥60,183,560.66 in Q1 2025, up 52.5% from ¥39,469,634.15 in Q1 2024[16] - Research and development expenses rose to CNY 56.44 million in Q1 2025, up 47% from CNY 38.47 million in Q1 2024[25] Assets and Liabilities - The total assets decreased by 5.28% to ¥4,669,329,953.32 from ¥4,929,616,758.84 at the end of the previous year[4] - The company's total assets amounted to RMB 4,669,329,953.32, down from RMB 4,929,616,758.84, indicating a reduction of 5.27%[13] - The total liabilities decreased to ¥3,133,109,291.17 from ¥3,246,050,681.41 year-over-year[15] - The total current liabilities decreased to ¥1,360,534,897.52 from ¥1,465,975,403.07 year-over-year[15] - The total owner's equity decreased from CNY 1,685.61 million to CNY 1,541.31 million year-over-year[22] Shareholder Structure - The company has a significant shareholder structure, with the top two shareholders holding a combined 70.05% of shares[10] - The largest shareholder, Nanjing Shichuang Venture Capital Co., Ltd., holds 35.74% of the shares[10] - The company has no significant changes in the shareholding structure due to margin trading or stock lending activities[11] Operational Insights - The company is focused on expanding its market presence and developing new technologies, although specific details were not disclosed in the call[10] - There are no significant reminders or additional important information regarding the company's operational status during the reporting period[12]

Financial Performance - The company has not achieved profitability since its listing[3]. - The company's operating revenue for 2024 reached ¥1,457,416,341.84, representing a 5.29% increase compared to ¥1,384,245,548.60 in 2023[24]. - The net profit attributable to shareholders for 2024 was ¥92,519,155.14, up 5.63% from ¥87,585,231.81 in 2023[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥83,169,338.77 for 2024, reflecting a 10.97% increase from ¥74,947,112.26 in 2023[24]. - The net cash flow from operating activities increased by 204.31% to ¥177,705,816.06, primarily due to the integration of Moandi in October 2023[25]. - The company's total assets grew by 12.02% to ¥2,842,515,132.82 in 2024, compared to ¥2,537,552,626.50 in 2023[24]. - The basic earnings per share remained stable at ¥0.49 for both 2024 and 2023[25]. - The weighted average return on equity decreased to 6.84% in 2024, down from 8.03% in 2023, a reduction of 1.19 percentage points[25]. - The company reported a net profit of ¥21,214,731.43 in Q1 2024, with a significant increase in net cash flow from operating activities to ¥121,692,521.38 in Q4 2024[29]. - The company incurred a loss of ¥24,261,965.16 in Q4 2024, contrasting with profits in the earlier quarters[29]. Research and Development - Research and development expenses accounted for 6.44% of operating revenue in 2024, an increase of 1.40 percentage points from 5.04% in 2023[25]. - The total R&D investment for the year was approximately ¥93.84 million, a significant increase of 34.51% compared to ¥69.77 million in the previous year[114]. - The company has developed a complete technology chain with 61 core technologies, including sorting and driving technologies, and has received national awards for its innovations[126]. - The R&D team includes 3 PhD holders and 17 master's degree holders, indicating a strong educational background[124]. - The number of R&D personnel increased to 240, up from 215, representing 20.10% of the total workforce[124]. - The company is focusing on enhancing its core technologies and global operations to maintain competitive advantages in the market[124]. Market Strategy and Expansion - The company plans to expand its market presence in Southeast Asia, targeting a 15% increase in market share by the end of 2024[13]. - The company is set to establish further partnerships with major cross-border e-commerce giants in 2024, aiming to provide intelligent logistics systems for global distribution centers[81]. - The company aims to become a global leader in intelligent logistics systems and core equipment by 2025-2030, transitioning from domestic to global leadership[184]. - The company plans to implement a Globalization 2.0 strategy, enhancing local operations and reducing overseas operational costs to improve competitiveness[185]. - The company is focusing on innovation in digitalization and intelligent core components, including advancements in robotics and AI technologies[186]. Corporate Governance - The company has not disclosed any special arrangements for corporate governance[8]. - The company has received a standard unqualified audit report from Zhonghui Certified Public Accountants[4]. - The company declared that all board members attended the board meeting[4]. - The company continues to focus on innovative logistics solutions, enhancing overall operational efficiency and safety[97]. - The company has continuously improved its corporate governance structure in accordance with relevant laws and regulations, ensuring accurate and complete information disclosure without any false records or significant omissions[197]. Technological Innovation - The company has developed a comprehensive range of smart logistics equipment, focusing on digital DC motors and intelligent drive control technology[43]. - The company has implemented digital twin technology in smart logistics and manufacturing systems, enhancing its core competitiveness through the integration of AI and IoT technologies[86]. - The company is committed to applying AI and IoT technologies in logistics equipment, developing a new generation of products with these technologies[190]. - The company has achieved a significant milestone with the implementation of a chainless conveyor technology, which allows for adjustable positioning and efficient movement of support legs, enhancing operational flexibility[98]. - The company has successfully integrated multiple technologies to create a high-precision intelligent detection assembly line, enhancing overall production capabilities[119]. Financial Management - The company’s total assets reached 2,840,000,000.00 RMB, with overseas assets accounting for 4.33% at 122,999,140.32 RMB[163]. - The company’s long-term borrowings increased by 102.55% to 232,745,459.79 RMB, indicating a significant reliance on bank loans[13]. - The company’s capital reserve increased by 40% to 188,389,762.00 RMB due to capital reserve conversion[17]. - The company’s investment activities generated a net cash outflow of ¥159,148,456.96, a significant decrease from a net inflow of ¥16,219,144.06 in the previous year, mainly due to increased construction costs for new facilities[160]. - The company is focusing on attracting talent in AI, robotics, IoT, and other advanced technologies to enhance its organizational capabilities[193]. Operational Efficiency - The company has achieved a defect rate of less than 0.5% in the assembly process through comprehensive quality monitoring techniques[120]. - The company has implemented a project management system for its system and key equipment business, allowing for production based on sales and customer demand[73]. - The company has established a full-process digitalization from project pre-sale to implementation and after-sales service, improving operational efficiency[68]. - The company is focusing on digital transformation, integrating multiple information management systems to enhance operational efficiency[48]. - The company is committed to reducing maintenance costs while ensuring the stability and sealing of its systems[118].

Business Focus and Restructuring - The company reported a significant shift in its main business focus from real estate to fine chemical products, with a restructuring completed in June 2020[16]. - The company has undergone several changes in its controlling shareholders, with the latest change occurring on July 1, 2023[16]. - The company operates in the fine chemical industry, focusing on pesticide and pharmaceutical intermediates, which are essential for drug production[28]. - The company is currently undergoing a process of issuing new shares, with multiple updates provided on the progress throughout the year[102]. Financial Performance - The company's operating revenue for 2024 was CNY 443,007,956.50, representing an increase of 18.71% compared to CNY 373,193,747.14 in 2023[17]. - The net profit attributable to shareholders for 2024 was CNY -105,034,809.41, a slight decrease of 0.73% from CNY -104,276,603.56 in 2023[17]. - The cash flow from operating activities for 2024 was CNY -982,703.47, a significant decline of 104.68% compared to CNY 21,001,609.14 in 2023[18]. - The company's net assets attributable to shareholders decreased by 261.33% to CNY -64,809,147.62 at the end of 2024 from CNY 40,172,858.16 at the end of 2023[18]. - The company reported a total operating revenue of CNY 437,149,480.16 after deducting certain amounts, compared to CNY 372,759,881.65 in 2023[19]. Risks and Uncertainties - The audit report issued by Lianda Accounting Firm includes a paragraph on significant uncertainty regarding the company's ability to continue as a going concern[3]. - The company has faced uncertainty regarding its ability to continue as a going concern, as indicated by the negative net profit figures over the past three years[18]. - The company emphasizes the importance of understanding the differences between plans, forecasts, and commitments due to inherent uncertainties in forward-looking statements[3]. - The company has outlined potential risks and corresponding countermeasures in the section discussing future development prospects[3]. Industry Trends and Market Position - The fine chemical industry is experiencing growth due to increasing demand for high-value-added products across various sectors, including healthcare and electronics[30]. - The pesticide intermediate industry is characterized by knowledge and technology intensity, requiring advanced process control and management expertise[31]. - China's pesticide intermediate industry is transitioning from imitation to independent innovation, with a focus on clean production processes and circular economy[32]. - The pharmaceutical intermediate industry in China is experiencing a supply surplus, with a growing reliance on imports for high-tech intermediates[33]. Production and Operations - The company’s production model is primarily based on sales-driven production, with a focus on customer-specific requirements and safety stock for stable demand products[46]. - The company has established a direct procurement model for raw materials, ensuring quality control and supplier management through a qualified supplier list[45]. - The company’s main raw materials include pyridine, liquid caustic soda, sodium hypochlorite, and liquid ammonia, with energy sources being electricity, steam, and water[46]. - The company is focused on expanding its product chain and improving production processes to enhance profitability[51]. Governance and Management - The company has been actively managing its governance structure to comply with regulatory requirements, ensuring independent operations from its controlling shareholders[106]. - The company has a strong academic presence on its board, with members like Jia Mingqi, who has published over 80 academic papers and holds various financial qualifications[116]. - The leadership team has a mix of technical and managerial expertise, with members like Liu Xiaomin, who has a background in chemical engineering and has held various managerial positions since 1994[117]. - The company is focused on maintaining a diverse and experienced board to enhance governance and strategic decision-making[121]. Environmental Compliance - The company has received various safety and environmental permits, ensuring compliance with regulatory standards[50]. - The company has invested approximately ¥30,783,631.43 in environmental governance and protection during the reporting period, with an environmental protection tax payment of ¥78,560.02[167]. - The company’s environmental protection measures have led to its recognition in the positive list of environmental management and as a "provincial green factory"[169]. - The company has established a three-level environmental risk accident prevention system to manage potential pollution incidents effectively[165]. Related Party Transactions - The company reported a related party transaction amounting to 1,566,000 CNY for raw material procurement, representing 36.19% of similar transactions[200]. - Another related party transaction was recorded at 2,761,000 CNY for raw material procurement, accounting for 63.81% of similar transactions[200]. - The pricing principles for these transactions are based on fair market value and reasonable pricing standards[200]. - The company anticipates that these transactions will support its supply chain stability and operational efficiency[200]. Future Outlook and Strategies - The company aims to enhance its competitive edge in the fine chemical industry by improving production lines and expanding product varieties, focusing on market-driven adjustments[86]. - The company plans to seek a second growth point while ensuring the main business continues to develop, aiming to discover potential business opportunities to improve operational performance[87]. - In 2025, the company will increase financing efforts to improve its debt situation and mitigate delisting risks, enhancing its sustainable operational capacity[88]. - The company will actively seek diversified financing channels, including strategic investors and equity financing, to enhance liquidity and optimize capital structure[89].

Financial Performance - The company's main business revenue declined year-on-year due to macroeconomic and market changes, resulting in a decrease in gross margin[4]. - The company reported a net loss during the reporting period after impairment tests on accounts receivable, contract assets, and goodwill[4]. - The company has not disclosed specific figures for revenue decline or net loss in the provided content[4]. - The company's operating revenue for 2024 was ¥688,197,120.08, a decrease of 2.43% compared to ¥705,353,969.88 in 2023[19]. - The net profit attributable to shareholders for 2024 was ¥49,349,567.6, reflecting a significant decline of 1,975.29% from ¥177,784,472 in 2022[19]. - The net cash flow from operating activities was negative at ¥71,770,266.4, a decrease of 316.08% compared to ¥33,215,162.80 in 2023[19]. - The total equity attributable to shareholders decreased by 11.88% to ¥374,258,077.35 at the end of 2024 from ¥424,735,417.78 in 2023[19]. - The company has faced uncertainty regarding its ability to continue as a going concern, as indicated by negative net profits over the last three accounting years[19]. - The company reported a quarterly operating revenue of ¥194,380,651.43 in Q4 2024, with a net profit attributable to shareholders of -¥51,592,414.58[21]. - The company experienced a significant increase in non-operating losses, totaling -¥1,404,490.31 in 2024 compared to a gain of ¥10,370,532.06 in 2023[24]. Business Strategy and Operations - The overall production and operation remain stable, with no significant adverse changes in the industry, main business, core competitiveness, or key financial indicators[4]. - The company continues to focus on maintaining its core business and competitive advantages despite the challenges faced[4]. - The company is engaged in the engineering supervision industry, providing project management consulting and technical services[28]. - The company has established a robust service network across all provinces, autonomous regions, and municipalities in mainland China, enabling rapid response to client needs[44]. - The company is actively pursuing a strategy of comprehensive service offerings, combining platforms, tools, and solutions for clients in the engineering sector[44]. - The company has been recognized as an advanced engineering supervision enterprise in Guangdong Province for several consecutive years, reflecting its strong reputation in the industry[45]. - The company has established a dual headquarters and key city group divisions to enhance regional market share and local service capabilities[58]. - The company has expanded its business coverage to all provinces, autonomous regions, and municipalities in mainland China, excluding Hong Kong, Macau, and Taiwan, which has increased operational management pressure[130]. Industry Trends and Market Outlook - The construction supervision industry in China achieved a revenue of CNY 1,582.802 billion in 2023, reflecting a steady increase from 2019 to 2023[34]. - The growth in revenue aligns with the overall development trend of the industry, supported by policies promoting market-oriented, international, and information-based supervision services[37]. - The introduction of new regulations and guidelines aims to enhance safety management and promote intelligent construction, which is expected to further drive industry growth[38]. - The construction supervision industry is expected to continue its upward trajectory, driven by policy support and the adoption of advanced technologies[37]. - The total revenue growth from 2019 to 2023 indicates a robust market response to the evolving regulatory landscape and industry demands[34]. Technology and Innovation - The company is focusing on the integration of digital technology with construction services, aiming for a comprehensive digital construction framework by 2027 and 2035[5]. - The company is leveraging advanced technologies such as IoT, 5G, BIM, AI, big data, and cloud computing to drive digital transformation and enhance smart construction capabilities[40]. - The company’s self-developed "Dali AI" model has improved supervision process efficiency by over 80% by integrating over 50,000 project experience data[59]. - The company is developing a vertical large model application software for the engineering supervision industry, which is expected to enhance its competitive position in intelligent services[93]. Financial Management and Governance - The financial report is guaranteed to be true, accurate, and complete by the company's management team[4]. - The company has a commitment to transparency in its financial reporting and disclosures[4]. - The company emphasizes information disclosure, adhering to relevant laws and regulations, and ensuring timely and fair access to information for all investors[144]. - The company maintains independence from its controlling shareholder, ensuring that major decisions are made autonomously without interference[138]. - The company has established a comprehensive governance structure in compliance with relevant laws and regulations, enhancing its internal control systems and information disclosure practices[136]. Human Resources and Talent Management - The company has implemented a three-pronged human resource strategy focusing on recruitment, training, and incentives to enhance workforce capabilities[58]. - The company is focused on optimizing its talent structure by continuously attracting management talent and enhancing performance assessments to reduce the risk of talent loss[132]. - The total number of employees at the end of the reporting period is 3,566, including 2,495 from the parent company and 1,071 from major subsidiaries[184]. - The company has established a competitive compensation system that reflects market value and employee contributions, with a focus on fairness and transparency in performance assessments[185]. Shareholder and Board Activities - The company plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves[5]. - The company held three shareholder meetings, ensuring equal rights for all shareholders, particularly minority shareholders, through a combination of online and in-person voting[137]. - The company held a total of 12 board meetings during the reporting period, with all directors actively participating[172]. - The board of directors consists of nine members, including three independent directors, who actively participate in meetings and training to ensure effective governance[139]. Future Outlook and Growth Plans - The company provided a future outlook with a revenue growth target of 10% for the upcoming fiscal year[152]. - The company plans to expand its market presence by entering three new provinces by the end of 2024, aiming for a 20% increase in market share[2]. - The company is exploring potential mergers and acquisitions to enhance its technological capabilities, targeting firms with complementary technologies[5]. - The company aims to transform into a full-process consulting enterprise, leveraging its resources and experience to expand profit margins in industrial projects[118].

Financial Performance - The company's revenue for Q1 2025 was ¥142,127,618.38, a decrease of 12.40% compared to ¥162,237,489.94 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥2,659,807.83, representing a decline of 606.45% from a profit of ¥525,190.94 in the previous year[5] - Basic earnings per share decreased to -¥0.0191 from ¥0.0039, a decline of 589.74%[5] - Total operating revenue for Q1 2025 was CNY 142.13 million, a decrease of 12.39% from CNY 162.24 million in the same period last year[21] - Net profit for Q1 2025 was a loss of CNY 2.43 million, compared to a profit of CNY 2.07 million in Q1 2024[22] - The company's gross profit margin decreased to -7.06% in Q1 2025 from 0.42% in Q1 2024[21] Cash Flow - The net cash flow from operating activities was negative at ¥40,237,335.35, worsening by 42.52% compared to the previous year's negative cash flow of ¥28,231,963.45[5] - Operating cash inflow for the current period was ¥136,990,035.63, a decrease of 14.8% from ¥160,776,551.52 in the previous period[24] - Cash inflow from investment activities totaled ¥8,111,042.46, down from ¥9,106,578.23 in the previous period, resulting in a net cash outflow of ¥9,163,708.70[25] - Cash inflow from financing activities was ¥50,445,275.93, a decrease of 31.0% from ¥73,205,694.24 in the previous period, with a net cash inflow of ¥27,378,029.46[25] - Total cash outflow from operating activities was ¥177,227,370.98, down from ¥189,008,514.97 in the previous period[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,384,105,333.45, an increase of 1.08% from ¥1,369,362,378.68 at the end of the previous year[5] - Total liabilities rose to CNY 983.41 million in Q1 2025, compared to CNY 967.96 million in the same period last year[19] - The company reported a cash balance of ¥160,181,880.28 as of March 31, 2025, down from ¥182,707,598.32 at the beginning of the period, indicating a decrease of approximately 12.8%[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 10,670, with the largest shareholder holding 10.01% of the shares[11] - The company’s major shareholder, Jinan Likong Disen Equity Investment Partnership, holds 14,031,261 shares, representing a significant portion of the equity[12] - The company’s second-largest shareholder, Wu Junye, holds 3,194,716 shares, accounting for 9.12% of the total shares[12] Investment and Expenses - The company reported a significant increase in investment income, which rose by 224.17% to ¥839,487.13 from ¥258,964.76 in the previous year[10] - Research and development expenses for Q1 2025 were CNY 12.73 million, a slight decrease from CNY 13.40 million in the previous year[22] - The company experienced a 217.34% increase in credit impairment losses, amounting to ¥1,326,698.76 compared to a loss of -¥1,130,667.31 in the same period last year[10] Changes and Acquisitions - The company completed the acquisition of 100% equity in Zhongda'an Consulting for no more than ¥5.5 million, with the agreement signed on August 8, 2024, and registration completed in February 2025[15] - The company has made changes to its registered capital and business scope, with the relevant procedures completed and a new business license issued on February 7, 2025[14] Other Financial Metrics - Other current liabilities increased by 37.38% to ¥107,625,153.95 from ¥78,338,877.20, primarily due to reclassification of certain notes[10] - Accounts receivable increased slightly to ¥192,710,550.47 from ¥191,395,067.59, reflecting a growth of about 0.7%[17] - Other receivables increased to ¥40,052,790.06 from ¥37,477,875.82, marking an increase of approximately 4.2%[17] - The company’s prepayments decreased to ¥59,074.85 from ¥103,411.96, showing a decline of about 42.8%[17]